DOI: 10.1021/acsapm.6c02074 ISSN: 2637-6105

From Passive Cargo to Active Skeleton: A pH-Responsive Polysaccharide Hydrogel Integrating Dipotassium Glycyrrhizinate as a Dynamic Cross-Linking Node for Scarless Wound Healing

Chaoqun You, Xinyue Ji, Like Ning, Xinying Liu, Junyang Fang, Delin Lu, Xietian Gu, Zhen Chen, Daihui Zhang, Rui Zhang, Xiaofeng Ding

Abstract

Traditional herbal-based wound dressings are often limited by low drug-loading capacity, inadequate infection control, and passive drug delivery. Here, we address these challenges by transforming dipotassium glycyrrhizinate (DG)─a natural herbal anti-inflammatory agent─from a conventional “passive cargo” into an active structural component of a polysaccharide hydrogel network. We developed a dynamically cross-linked hydrogel (HCC-DG-Cu) by integrating DG with hyaluronic acid (HA), chitosan (CS), and carboxymethyl cellulose (CMC) via hydrogen bonding, electrostatic interactions, and dynamic Cu2+ coordination. This design paradigm shift yields three key advances: (1) ultrahigh drug loading (∼55%, ≈30% higher than conventional polysaccharide hydrogels) by incorporating DG as a network-integrated building block rather than a physically loaded additive; (2) pH-responsive release (≈95% at pH 9.0 vs ≈54% at pH 5.5) leveraging Cu2+ coordination dynamics; (3) synergistic antibacterial activity (>90% inhibition against S. aureus and E. coli) and potent anti-inflammatory effects without conventional antibiotics. In an E. coli-infected full-thickness wound model, the HCC-DG-Cu hydrogel significantly accelerated wound closure, promoted orderly collagen deposition, enhanced angiogenesis (CD31+/VEGF+), and minimized scar formation─outcomes attributed to the sustained, microenvironment-modulating release of DG from the dynamic network. This work establishes a clear structure–function–therapeutic efficacy correlation and presents a generalizable strategy to upgrade passive herbal-loaded dressings into active, multifunctional regenerative platforms.

More from our Archive